INFORMED.
LIVE

Indoco Remedies Ltd.

BSE: INDOCO532612ISIN INE873D01024
  • Healthcare
  • Pharmaceuticals
  • BSE 1000

Share price

₹249.35-5.10 (-2.00%)
as of 18 Sep 2026
Indoco Remedies Ltd. share price, 18 Sep 2025 to 18 Sep 2026: ₹302.00 to ₹249.35 (-17.4%). Low ₹173.65, high ₹302.65. Volume shown below the price.
52W high
₹317.10
52W low
₹163.70
Off 52W high
-21.37%
1M return
+14.28%
3M return
+5.84%
6M return
+30.35%
1Y return
-17.43%
20D avg volume
63,614
50 DMA
₹237.69
200 DMA
₹222.71

Key ratios Consolidated

Market cap
₹2,302 Cr
Current price
₹249.35
52W high / low
₹317.10 / ₹163.70
Face value
₹2.00
P/E
742.45
P/B
EPS (TTM)
₹0.34
Book value / share
ROE
ROCE
1.00%
Operating margin
Net margin
Debt / equity
1.11
Net debt
₹1,010 Cr
Interest cover
0.13
Dividend yield
0.08%
Dividend / share (TTM)
₹0.20
Payout
58.82%
Cash conversion cycle
115.9 days

Financials

MetricQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q4 FY24
Income statement
467.50475.61445.36484.67437.89390.21
2.18-0.040.980.761.632.02
489.30504.31471.50498.43476.18437.75
104.58109.1897.89112.99105.5385.86
39.8932.5232.9938.8239.2330.62
101.41109.41106.03103.23107.02106.36
28.2945.9225.6424.5626.1217.98
34.5332.4932.0132.2529.7028.78
167.02175.48187.40193.05178.37178.66
-19.62-28.74-25.16-13.00-36.66-45.52
97.343.74-6.15-0.530.000.00
77.72-25.00-31.31-13.53-36.66-45.52
12.28-1.32-1.86-4.32-0.31-4.18
65.44-23.68-29.45-9.21-36.35-41.34
7.09-2.57-3.20-1.00-3.94-4.48
Key metrics
140.5453.4126.3443.2819.161.24
30.10%11.20%5.90%8.90%4.40%0.30%
14.00%-5.00%-6.60%-1.90%-8.30%-10.60%
1.40%0.70%-1.70%
6.80%21.90%
280.00%42.70%
MetricTTMFY26FY25FY24
Income statement
1,8731,8451,665
3.883.335.45
1,9641,9521,746
424.64425.60396.27
144.22143.55140.93
420.08425.69394.05
124.41122.2566.23
131.28126.45113.84
722.95736.09673.43
-86.52-103.57-75.36
94.40-2.940.99
7.88-106.51-74.37
4.78-7.813.58
3.10-98.70-77.95
0.32-10.708.46
Key metrics
263.57142.19105.70
14.07%7.70%6.30%
0.17%-5.30%-4.70%
1.00%-0.50%
10.80%
-26.60%
44.70-261.22
-1.95-1.22
1.110.98
1,010981.46
115.9123.6
Balance sheet
2,5932,430
1,1931,001
25.9312.10
489.17352.41
405.21419.35
226.92187.45
969.83849.06
308.52208.13
1,053807.99
1,036993.56
519.83451.00
516.02542.56
932.111,018
Cash flow
192.2394.93
-101.61-339.11
-76.80241.42
147.53356.15
MetricQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q4 FY24
Income statement
408.97449.13400.51442.12392.53347.25
4.4710.357.176.545.586.50
417.56435.54422.12438.37426.51384.65
85.9998.2581.1986.0287.7772.22
39.5929.0832.9938.8239.2330.62
90.65100.9898.8195.3498.5099.94
22.7522.7320.1522.0123.6115.98
28.0526.7127.3627.6325.2024.88
135.66147.21163.21164.51158.03153.99
-4.1223.94-14.4410.29-28.40-30.90
97.343.68-6.01-0.530.000.00
93.2227.62-20.459.76-28.40-30.90
10.900.27-0.45-5.29-0.34-4.66
82.3227.35-20.0015.05-28.06-26.24
8.922.96-2.171.63-3.04-2.85
Key metrics
144.0277.0627.0659.4020.419.96
35.20%17.20%6.80%13.40%5.20%2.90%
20.10%6.10%-5.00%3.40%-7.10%-7.60%
3.40%2.10%-1.00%
4.20%29.30%
393.40%204.20%
MetricTTMFY26FY25FY24
Income statement
1,7011,6861,518
28.5329.6418.48
1,7141,7241,545
351.45353.23334.79
140.48140.12140.93
385.78393.63368.74
87.6488.5056.63
109.75106.9098.25
610.59634.74577.73
15.67-8.61-8.36
94.48-2.860.99
110.15-11.47-7.37
5.43-5.811.36
104.72-5.66-8.73
11.34-0.61-0.95
Key metrics
307.54183.93147.51
18.08%10.90%9.70%
6.16%-0.30%-0.60%
5.20%3.30%
11.10%
35.20%
101.00-167.66
-39.99-10.40
0.640.68
692.66746.46
130.5141.7
Balance sheet
2,3652,201
1,114955.47
12.947.06
541.20374.05
321.83362.87
169.18140.51
703.46670.62
260.55147.38
875.47695.01
705.60753.52
403.99407.27
301.61346.25
1,0991,103
Cash flow
226.3590.77
-87.38-259.79
-133.09168.62
125.35258.43

Compounded growth

Standalone

Sales CAGR 3Y
Sales CAGR 5Y
Sales CAGR 10Y
Profit CAGR 3Y
Profit CAGR 5Y
Profit CAGR 10Y
Sales YoY (TTM)
Profit YoY (TTM)

Consolidated

Sales CAGR 3Y
Sales CAGR 5Y
Sales CAGR 10Y
Profit CAGR 3Y
Profit CAGR 5Y
Profit CAGR 10Y
Sales YoY (TTM)
Profit YoY (TTM)

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding
58.87%
HolderTypeHoldingPreviousChange
SPA HOLDINGS PVT LTDPromoter Group19.86%
SHANTERI INVESTMENT PVT LTDPromoter17.18%
KARE FAMILY PRIVATE TRUSTPromoter14.19%
NIPPON LIFE INDIA TRUSTEE LTD A/C NIPPON INDIA SMALL CAP FUNDPublic4.80%
QUANT MUTUAL FUND QUANT SMALL CAP FUNDPublic4.55%
DSP HEALTHCARE FUNDPublic4.34%
PANANDIKAR ADITI MILINDPromoter3.16%
MADHURA SURESH KAREPromoter2.69%
ICICI PRUDENTIAL PHARMA HEALTHCARE AND DIAGANOSTICS (P.H.D.) FUNDPublic1.80%
HDFC VALUE FUNDPublic1.66%
KARE SURESH GOVINDPromoter1.40%
MANGESHI INVESTMENT PRIVATE LIMITEDPublic1.26%
SURESH GOVIND KARE HUF (Karta- Suresh Govind Kare)Promoter0.30%
SHARDA RAMNATH KAREPromoter Group0.04%
PRATIMA AJIT VAIDYAPromoter Group0.03%

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

Corporate actions

PurposeEx dateRecord datePayment date
Final Dividend - Rs. - 0.200010 Sep 202610 Sep 2026
Final Dividend - Rs. - 0.20004 Sep 20254 Sep 2025
Final Dividend - Rs. - 1.500019 Sep 2024

Board meetings

  • Board Meeting - Financial Results